These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38589525)

  • 1. The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases.
    Hussein NA; Ebid SA; Ahmad MA; Khedr GE; Saad DM
    Sci Rep; 2024 Apr; 14(1):8246. PubMed ID: 38589525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hippo pathway in colorectal cancer.
    Liang K; Zhou G; Zhang Q; Li J; Zhang C
    Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
    Song L; Huang Y; Zhang X; Han S; Hou M; Li H
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
    Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.
    Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X
    J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
    Lin CW; Chang YL; Chang YC; Lin JC; Chen CC; Pan SH; Wu CT; Chen HY; Yang SC; Hong TM; Yang PC
    Nat Commun; 2013; 4():1877. PubMed ID: 23695671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MiR-10b Restrains the Migration and Epithelial-Mesenchymal Transition of Lung Cells by Targeting LATS2 via TAZ Pathway.
    Yang Y; Wang J
    Med Sci Monit; 2020 May; 26():e920275. PubMed ID: 32361707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
    Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
    Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway.
    An Y; Zhang Q; Li X; Wang Z; Li Y; Tang X
    Biomed Pharmacother; 2018 Dec; 108():1845-1855. PubMed ID: 30372890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
    Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
    Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
    Liu W; Huang Y; Wang D; Han F; Chen H; Chen J; Jiang X; Cao J; Liu J
    Oncogene; 2021 Jul; 40(26):4468-4485. PubMed ID: 34108620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.